THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 93 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,186,000 | +76.5% | 97,513 | +22.5% | 0.02% | +75.0% |
| Q2 2018 | $1,805,000 | +2.6% | 79,607 | +9.7% | 0.01% | -14.3% |
| Q1 2018 | $1,760,000 | +5.3% | 72,564 | +21.0% | 0.01% | +16.7% |
| Q4 2017 | $1,672,000 | -7.9% | 59,951 | +13.1% | 0.01% | -7.7% |
| Q3 2017 | $1,815,000 | -5.2% | 53,013 | +10.3% | 0.01% | 0.0% |
| Q2 2017 | $1,915,000 | +591.3% | 48,069 | +201.1% | 0.01% | +550.0% |
| Q1 2015 | $277,000 | – | 15,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |